Appointment booking for Dr. Leo Clavecilla, MD is currently not available.Dr. Leo Clavecilla, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Leo Clavecilla, MD is a Internist in Akron, OH with over 18 years of experience. What is your opinion of Dr. Leo Clavecilla, MD? Rate this provider below so other people can make informed decision.
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Leo Clavecilla, MD has received over $1,036 which includes payments from the following companies:
$234.24 from Pfizer Inc.
$178.79 from GlaxoSmithKline, LLC.
$160.74 from Novartis Pharmaceuticals Corporation
$82.81 from Amgen Inc.
$58.87 from AbbVie, Inc.
$48.46 from Novo Nordisk Inc
$48.07 from Boehringer Ingelheim Pharmaceuticals, Inc.
$28.71 from Amarin Pharma Inc.
$28.31 from Scilex Pharmaceuticals Inc.
$27.44 from Allergan Inc.
$26.22 from E.R. Squibb & Sons, L.L.C.
$18.68 from UCB, Inc.
$18.19 from Dynavax Technologies Corporation
$17.30 from AstraZeneca Pharmaceuticals LP
$14.73 from Mylan Specialty L.P.
$11.62 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$11.46 from Sanofi Pasteur Inc.
$11.13 from Janssen Pharmaceuticals, Inc
$10.98 from Merck Sharp & Dohme Corporation
Payments received by Dr. Leo Clavecilla, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!